Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Topical X0002 in Healthy Volunteers
NCT02794740Phase 1Completed
- Start
- Jun 2016
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of X0002 Placebo Spray in osteoarthritis (OA) (7 arms). Primary endpoint: Incidence of adverse events at 17 days. Started Jun 2016; status: completed.
02
Drugs
X0002 Placebo Spray
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02794740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794740.